register

Leadership & Management

B. Braun appoints new country leader in an internal promotion

Health Industry Hub | July 3, 2024 |

Leadership & Management: Following the promotion of current leader, Christian Gabriel, to Managing Director of B. Braun Switzerland, B. Braun Australia has announced the appointment of Geoff Brown as its new Managing Director.

Brown, who joined B. Braun in 2010, has held several commercial and leadership roles during his tenure with the company. B. Braun, a family-owned medtech company, employs 63,000 people globally.

“His extensive experience, empathetic leadership, and deep understanding of our business are invaluable assets that will drive B. Braun Australia, New Zealand, and the Pacific Islands to success in the future,” the company stated.

The company expressed its gratitude for Gabriel’s contributions, saying, “We are ever grateful for Christian’s hard work, dedication, and most importantly, his friendly face as he led us through some extraordinary circumstances over the last six years. His contribution and commitment have been integral to our success.”

Earlier this year, B. Braun was recognised with the IV Product Innovation of the Year at the Healthcare Asia Medtech Awards for its Introcan Safety 2 IV Catheter. This peripheral intravenous catheter features passive needlestick prevention and a multi-access blood control septum, designed for blood sampling, blood pressure monitoring, and administering fluids and blood intravascularly. It is also indicated for subcutaneous infusion therapies.

Globally, B. Braun’s orthobiologics business was acquired by Octane Medical Group in June. The orthobiologics platform includes two regenerative medicines: Novocart 3D, which involves implanting a collagen-based matrix scaffold seeded with cartilage cells into defective areas, and Novocart Inject, an injectable mixture of cartilage cells and PEG-albumin-hyaluronic acid hydrogel.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Federal court dismisses Arrotex dispute against Health Minister

Federal court dismisses Arrotex dispute against Health Minister

Health Industry Hub | July 12, 2024 |

Pharma News: The Federal Court has ruled against Arrotex Pharmaceuticals in their bid to challenge the Minister for Health and […]

More


News & Trends - Pharmaceuticals

Largest diabetes study reveals major benefits of dual therapy with SGLT2 inhibitors and GLP1 receptor agonists

Largest diabetes study reveals major benefits of SGLT2 inhibitors and GLP1 receptor agonists dual therapy

Health Industry Hub | July 12, 2024 |

Pharma News: Combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to […]

More


News & Trends - Pharmaceuticals

Queensland opens first regional CAR T-cell treatment centre

Queensland launches first regional CAR T-cell treatment centre

Health Industry Hub | July 12, 2024 |

Pharma News: Gilead Sciences and Lymphoma Australia have welcomed the opening of Australia’s first regional CAR T-cell treatment centre at […]

More


News & Trends - Pharmaceuticals

Government inaction leaves essential medicine shortages unresolved

Government inaction leaves essential medicine shortages unresolved

Health Industry Hub | July 12, 2024 |

Pharma News: Over the past 12 months, at least six essential medications and products have been withdrawn from the Australian […]

More


This content is copyright protected. Please subscribe to gain access.